Key factors
sym | PFE |
exch | US |
MCap | 148.78B |
Beta | 0.572 |
PE Ratio | 71.01 |
EPS | 0.37 |
Div | 1.64 |
Div Yld | 6.379 |
Div date | 2024-01-25 |
Yesterday
sym | PFE |
exch | US |
close | 25.39 |
50 Day MA | 27.28 |
200 Day MA | 31.06 |
52 Week High | 39.30 |
52 Week Low | 25.37 |
Target Price | 28.95 |
Market Cap Mln | 148.78K |
Share statistics
Shares Outstanding | 5.662B |
Shares Float | 5.638B |
Percent Institutions | 69.96 |
PercentInsiders | 0.047 |
SharesShort | 64.99M |
Short Ratio | 1.4 |
Shares Short Prior Month | 66.11M |
Short Percent | 1.150 |
Income
Revenue TTM | 58.49B |
Revenue Per Share TTM | 10.36 |
Quarterly Revenue Growth YOY | -41.2 |
Gross Profit TTM | 66.23B |
EBITDA | 11.51B |
Diluted Eps TTM | 0.37 |
Quarterly Earnings Growth YOY | -76.3 |
earning
Operating Margin TTM | -0.49 |
PEGRatio | 0.263 |
Trailing PE | 71.01 |
EPS Estimate Current Quarter | -0.2 |
EPS Estimate Current Year | 2.05 |
EPS Estimate Next Quarter | 0.53 |
EPS Estimate Next Year | 2.55 |
Earnings Share | 0.37 |
Dividend
Forward Annual Dividend Rate | 1.68 |
Forward Annual Dividend Yield | 6.379 |
Payout Ratio | 90.16 |
Dividend Date | 2024-03-01 |
Last Split Date | 2020-11-17 |
Last Split Factor | 1054:1000 |
business
Enterprise Value Ebitda | 21.69 |
Enterprise Value Revenue | 3.543 |
Book Value /share | 15.76 |
Price Book MRQ | 1.675 |
Price Sales TTM | 2.540 |
ProfitMargin | 0.036 |
ReturnOnAssetsTTM | 0.015 |
ReturnOnEquityTTM | 0.023 |
Sector
Gic Group | Pharmaceuticals, Biotechnology & Life Sciences |
Gic Industry | Pharmaceuticals |
Gic Sector | Health Care |
Gic Sub Industry | Pharmaceuticals |
Industry | Drug Manufacturers - General |
Sector | Healthcare |
Codes
ISIN | US7170811035 |
CIK | 78003 |
Code | PFE |
CUSIP | 717081103 |
Employer Id Number | 13-5315170 |
CountryISO | US |
Currency Code | USD |
Currency Name | US Dollar |
Exchange | NYSE |
Currency Symbol | $ |
fund
Type | Common Stock |
UpdatedAt | 2024-04-12 |
Home Category | Domestic |
info
Fiscal Year End | December |
ForwardPE | 12.01 |
Full Time Employees | 88000 |
IPODate | 2012-08-13 |
International Domestic | International Domestic |
MostRecent Quarter | 2023-12-31 |
Contact
Name | Pfizer Inc |
Address | 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 |
Country Name | USA |
Phone | 212 733 2323 |
Web URL | https://www.pfizer.com |
Logo URL | /img/logos/US/pfe.png |
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.